Gilead Suffers First Hep C Drug Setback
Gilead Suffers First Hep C Drug Setback TheStreet.com
View ArticleAchillion, Vertex rally on Gilead's woes
Achillion, Vertex rally on Gilead's woes Marketwatch
View Article1 Biotech Punished by Hep-C Overreaction
1 Biotech Punished by Hep-C Overreaction Motley Fool
View ArticleBristol-Gilead Hep C Drug Data Leaks
Bristol-Gilead Hep C Drug Data Leaks TheStreet.com
View ArticleGilead Bets on Hepatitis C Data to Back Pharmasset Deal
Gilead Bets on Hepatitis C Data to Back Pharmasset Deal Bloomberg
View ArticleGilead Sciences' Hepatitis Drug in Spotlight at Major Medical Meeting
Gilead Sciences' Hepatitis Drug in Spotlight at Major Medical Meeting Minyanville
View ArticleGilead Rises After Hepatitis Data Open New Test Options
Gilead Rises After Hepatitis Data Open New Test Options Bloomberg
View ArticleGilead, Bristol Shine at EASL Conference
Gilead, Bristol Shine at EASL Conference Motley Fool
View ArticleGilead's Hepatitis C Drug Poised To Reach The Market As One Of The First 'All...
Gilead's Hepatitis C Drug Poised To Reach The Market As One Of The First 'All Oral' Combinations Seeking Alpha
View ArticleBristol CEO says Gilead holding out on hep C tie-up
Bristol CEO says Gilead holding out on hep C tie-up Fierce Biotech
View ArticleGilead Begins Single Pill Hepatitis C Study For 2014 Approval
Gilead Begins Single Pill Hepatitis C Study For 2014 Approval Bloomberg
View ArticleForget the Numbers, This Pipeline Is King
Forget the Numbers, This Pipeline Is King Motley Fool
View ArticleGuilt by Association = 30% Slaughter?
Guilt by Association = 30% Slaughter? Motley Fool
View ArticleGilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis...
Gilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis Drugs for Future Minyanville
View ArticleBlockbuster buzz: 15 top therapies in late-stage development
Blockbuster buzz: 15 top therapies in late-stage development Fierce Biotech
View Article5 Things to Watch This Week in the Health-Care Sector
5 Things to Watch This Week in the Health-Care Sector Motley Fool
View ArticleGilead Climbs on Study Results of Hepatitis C Combo
Gilead Climbs on Study Results of Hepatitis C Combo Bloomberg
View ArticleGilead Shares Hit All-Time High On Positive Trial For Hep C Drug
Gilead Shares Hit All-Time High On Positive Trial For Hep C Drug Yahoo/Investors Business Daily
View Article